NM_001101648.2:c.-133A>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001101648.2(NPC1L1):​c.-133A>G variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.268 in 759,692 control chromosomes in the GnomAD database, including 31,190 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.22 ( 4712 hom., cov: 33)
Exomes 𝑓: 0.28 ( 26478 hom. )

Consequence

NPC1L1
NM_001101648.2 upstream_gene

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.434

Publications

30 publications found
Variant links:
Genes affected
NPC1L1 (HGNC:7898): (NPC1 like intracellular cholesterol transporter 1) The protein encoded by this gene is a multi-pass membrane protein. It contains a conserved N-terminal Niemann-Pick C1 (NPC1) domain and a putative sterol-sensing domain (SSD) which includes a YQRL motif functioning as a plasma membrane to trans-Golgi network transport signal in other proteins. This protein takes up free cholesterol into cells through vesicular endocytosis and plays a critical role in the absorption of intestinal cholesterol. It also has the ability to transport alpha-tocopherol (vitamin E). The drug ezetimibe targets this protein and inhibits the absorption of intestinal cholesterol and alpha-tocopherol. In addition, this protein may play a critical role in regulating lipid metabolism. Polymorphic variations in this gene are associated with plasma total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels and coronary heart disease (CHD) risk. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.312 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NPC1L1NM_001101648.2 linkc.-133A>G upstream_gene_variant ENST00000381160.8 NP_001095118.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NPC1L1ENST00000381160.8 linkc.-133A>G upstream_gene_variant 1 NM_001101648.2 ENSP00000370552.3
NPC1L1ENST00000289547.8 linkc.-133A>G upstream_gene_variant 1 ENSP00000289547.4
NPC1L1ENST00000546276.5 linkc.-133A>G upstream_gene_variant 1 ENSP00000438033.1
NPC1L1ENST00000423141.1 linkc.-133A>G upstream_gene_variant 1 ENSP00000404670.1

Frequencies

GnomAD3 genomes
AF:
0.219
AC:
33315
AN:
152094
Hom.:
4712
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0644
Gnomad AMI
AF:
0.432
Gnomad AMR
AF:
0.241
Gnomad ASJ
AF:
0.270
Gnomad EAS
AF:
0.00964
Gnomad SAS
AF:
0.226
Gnomad FIN
AF:
0.226
Gnomad MID
AF:
0.263
Gnomad NFE
AF:
0.316
Gnomad OTH
AF:
0.259
GnomAD4 exome
AF:
0.280
AC:
170341
AN:
607480
Hom.:
26478
AF XY:
0.280
AC XY:
87414
AN XY:
312004
show subpopulations
African (AFR)
AF:
0.0593
AC:
957
AN:
16148
American (AMR)
AF:
0.230
AC:
5018
AN:
21820
Ashkenazi Jewish (ASJ)
AF:
0.279
AC:
4151
AN:
14900
East Asian (EAS)
AF:
0.0121
AC:
383
AN:
31584
South Asian (SAS)
AF:
0.249
AC:
12283
AN:
49428
European-Finnish (FIN)
AF:
0.235
AC:
7418
AN:
31510
Middle Eastern (MID)
AF:
0.295
AC:
1150
AN:
3896
European-Non Finnish (NFE)
AF:
0.321
AC:
130715
AN:
406738
Other (OTH)
AF:
0.263
AC:
8266
AN:
31456
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
5747
11494
17240
22987
28734
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2328
4656
6984
9312
11640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.219
AC:
33313
AN:
152212
Hom.:
4712
Cov.:
33
AF XY:
0.213
AC XY:
15870
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.0643
AC:
2673
AN:
41550
American (AMR)
AF:
0.241
AC:
3688
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.270
AC:
936
AN:
3472
East Asian (EAS)
AF:
0.00947
AC:
49
AN:
5176
South Asian (SAS)
AF:
0.226
AC:
1092
AN:
4832
European-Finnish (FIN)
AF:
0.226
AC:
2395
AN:
10596
Middle Eastern (MID)
AF:
0.255
AC:
75
AN:
294
European-Non Finnish (NFE)
AF:
0.316
AC:
21471
AN:
67978
Other (OTH)
AF:
0.256
AC:
541
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1277
2554
3831
5108
6385
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
354
708
1062
1416
1770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.278
Hom.:
20817
Bravo
AF:
0.213
Asia WGS
AF:
0.122
AC:
426
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
13
DANN
Benign
0.71
PhyloP100
-0.43
PromoterAI
0.075
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17655652; hg19: chr7-44580991; API